비교리스트

 카트 문의
시장보고서
상품코드
1360304

라임병 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Lyme Disease Diagnostics Market (Diagnostic Test: Serological Test, Polymerase Chain Reaction Test, and Others; and Sample: Blood, Cerebrospinal Fluid, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

라임병 진단 시장 - 리포트의 범위

세계의 라임병 진단 시장에 관한 TMR의 리포트는 과거와 현재의 성장 동향 및 2023-2031년의 예측 기간 중 시장 지표의 귀중한 인사이트를 얻을 기회를 연구하고 있습니다. 이 리포트는 세계의 라임병 진단 매출을 제공합니다. 2023년을 기준년, 2031년을 예측년으로 간주하고, 2017-2031년 기간 시장을 분석합니다. 리포트는 2023-2031년 세계의 라임병 진단 시장의 연평균 성장률(CAGR %)도 제공합니다.

이 리포트는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분이 시행되고, 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 제조업체와 인터뷰를 진행했습니다. 2차 조사에는 라임병 진단 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차보고서, 프레스 릴리스 및 관련 문서 참조가 포함됩니다.

시장 스냅숏
2023년 시장 가치 15억 달러
2031년 시장 가치 21억 달러
CAGR 3.8%

이 리포트는 세계의 라임병 진단 시장의 경쟁 구도를 상세 분석하고 있습니다. 세계의 라임병 진단 시장에서 활동하는 주요 기업이 식별되고, 각각의 기업이 다양한 속성의 측면에서 프로파일링되고 있습니다. 회사 개요, 재무 상황, 최근 동향, SWOT는 이 리포트에서 소개되고 있는 세계의 라임병 진단 시장에서 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장의 분석과 예측, 2017-2031년

제5장 주요 인사이트

  • 라임병 진단 검사에서의 혁신
  • 라임병의 발생률과 유병률
  • 지역/세계별 규제 시나리오
  • COVID-19 팬데믹의 업계에 대한 영향(밸류체인과 단기·중기·장기적인 영향)

제6장 세계 시장의 분석과 예측 : 진단 테스트별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 금액 예측 : 진단 테스트별, 2017-2031
    • 혈청학적 검사
      • ELISA
      • 웨스턴 블롯
    • 중합효소 연쇄 반응(PCR) 검사
    • 기타
  • 시장의 매력 분석 : 진단 테스트별

제7장 세계 시장의 분석과 예측 : 샘플별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 금액 예측 : 샘플별, 2017-2031
    • 혈액
    • 뇌척수액(CSF)
    • 기타
  • 시장의 매력 분석 : 샘플별

제8장 세계 시장의 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 금액 예측 : 최종사용자별, 2017-2031
    • 병원
    • 진단 연구소
    • 기타
  • 시장의 매력 분석 : 최종사용자별

제9장 세계 시장의 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 금액 예측 : 지역별, 2017-2031
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업의 계층 및 규모별)
  • 시장 점유율 분석 : 기업별(2022년)
  • 기업 개요
    • LabCorp
    • Quest Diagnostics
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • DiaSorin SpA
    • T2 Biosystems, Inc.
    • F. Hoffmann-La Roche AG
    • Meridian Bioscience, Inc.
    • Quidel Corporation
KSA 23.10.25

Lyme Disease Diagnostics Market - Scope of Report

TMR's report on the global lyme disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global lyme disease diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global lyme disease diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the lyme disease diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.5 Bn
Market Value in 2031US$ 2.1 Bn
CAGR3.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyme disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global lyme disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global lyme disease diagnostics market.

The report delves into the competitive landscape of the global lyme disease diagnostics market. Key players operating in the global lyme disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global lyme disease diagnostics market profiled in this report.

Key Questions Answered in Global Lyme Disease Diagnostics Market Report:

  • What is the sales/revenue generated by lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global lyme disease diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Lyme Disease Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global lyme disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global lyme disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global lyme disease diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Lyme Disease Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Lyme Disease Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projection (US$ Mn)

5. Key Insights

  • 5.1. Innovations in Diagnostic Testing for Lyme disease
  • 5.2. Incidence and Prevalence of Lyme Disease
  • 5.3. Regulatory Scenario by Region/Globally
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)

6. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Diagnostic Test

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 6.3.1. Serological Test
      • 6.3.1.1. ELISA
      • 6.3.1.2. Western Blot
    • 6.3.2. Polymerase Chain Reaction (PCR) test
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Diagnostic Test

7. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Sample

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Sample, 2017-2031
    • 7.3.1. Blood
    • 7.3.2. Cerebrospinal Fluid (CSF)
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Sample

8. Global Lyme Disease Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Lyme Disease Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 10.2.1. Serological Test
      • 10.2.1.1. ELISA
      • 10.2.1.2. Western Blot
    • 10.2.2. Polymerase Chain Reaction (PCR) test
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Sample, 2017-2031
    • 10.3.1. Blood
    • 10.3.2. Cerebrospinal Fluid (CSF)
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Diagnostic Test
    • 10.6.2. By Sample
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Lyme Disease Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 11.2.1. Serological Test
      • 11.2.1.1. ELISA
      • 11.2.1.2. Western Blot
    • 11.2.2. Polymerase Chain Reaction (PCR) test
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Sample, 2017-2031
    • 11.3.1. Blood
    • 11.3.2. Cerebrospinal Fluid (CSF)
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Diagnostic Test
    • 11.6.2. By Sample
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Lyme Disease Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 12.2.1. Serological Test
      • 12.2.1.1. ELISA
      • 12.2.1.2. Western Blot
    • 12.2.2. Polymerase Chain Reaction (PCR) test
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Sample, 2017-2031
    • 12.3.1. Blood
    • 12.3.2. Cerebrospinal Fluid (CSF)
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Diagnostic Test
    • 12.6.2. By Sample
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Lyme Disease Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 13.2.1. Serological Test
      • 13.2.1.1. ELISA
      • 13.2.1.2. Western Blot
    • 13.2.2. Polymerase Chain Reaction (PCR) test
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Sample, 2017-2031
    • 13.3.1. Blood
    • 13.3.2. Cerebrospinal Fluid (CSF)
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Diagnostic Test
    • 13.6.2. By Sample
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Lyme Disease Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 14.2.1. Serological Test
      • 14.2.1.1. ELISA
      • 14.2.1.2. Western Blot
    • 14.2.2. Polymerase Chain Reaction (PCR) test
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Sample, 2017-2031
    • 14.3.1. Blood
    • 14.3.2. Cerebrospinal Fluid (CSF)
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Diagnostic Test
    • 14.6.2. By Sample
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. LabCorp
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Quest Diagnostics
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Abbott Laboratories
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Bio-Rad Laboratories, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. bioMerieux SA
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. DiaSorin S.p.A.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. T2 Biosystems, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. F. Hoffmann-La Roche AG
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Meridian Bioscience, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Quidel Corporation
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제